Sally Baron‐Hay

Veliparib with First-Line Chemotherapy and as Maintenance Therapy in Ovarian Cancer

Robert L. Coleman, Gini F. Fleming, Mark F. Brady et al. · New England Journal of Medicine · 2019 · 886 citations · Full text

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 157 citations

Medicine, Metronomic Therapy, Gynecology +8

Small cell of the ovary, hypercalcemic type—Analysis of combined experience and recommendation for management. A GCIG study

Michelle Harrison, Paul Hoskins, Andreas du Bois et al. · Gynecologic Oncology · 2005 · 145 citations

Infertility, Gcig Study, Combined Experience +12

Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial

Nadia Harbeck, Eva Ciruelos, Guy Jérusalem et al. · Nature Medicine · 2024 · 141 citations · Full text

Lenvatinib Plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: Updated Efficacy and Safety From the Randomized Phase III Study 309/KEYNOTE-775

Vicky Makker, Nicoletta Colombo, Antonio Casado et al. · Journal of Clinical Oncology · 2023 · 123 citations · Full text